Humoral response after a BNT162b2 heterologous third dose of COVID-19 vaccine following two doses of BBIBP-CorV among healthcare personnel in Peru

Background: The inactivated virus vaccine, BBIBP-CorV, was principally distributed across low- and middle-income countries as primary vaccination strategy to prevent poor COVID-19 outcomes. Limited information is available regarding its effect on heterologous boosting. We aim to evaluate the immunog...

Full description

Bibliographic Details

Published in:	Vaccine: X
Main Authors:	Stephanie Montero, Diego Urrunaga-Pastor, Percy Soto-Becerra, Aleksandar Cvetkovic-Vega, Martina Guillermo-Roman, Luis Figueroa-Montes, Arturo A. Sagástegui, Sergio Alvizuri-Pastor, Roxana M. Contreras-Macazana, Moisés Apolaya-Segura, Cristian Díaz-Vélez, Jorge L. Maguiña
Format:	Article
Language:	English
Published:	Elsevier 2023-08-01
Subjects:	COVID-19 SARS-CoV-2 Vaccination Vaccine Booster
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590136223000529